Suppr超能文献

人群异质性与冠状动脉疾病多基因评分的选择

Population Heterogeneity and Selection of Coronary Artery Disease Polygenic Scores.

作者信息

Debernardi Carla, Savoca Angelo, De Gregorio Alessandro, Casalone Elisabetta, Rosselli Miriam, Herman Elton Jalis, Di Primio Cecilia, Tumino Rosario, Sieri Sabina, Vineis Paolo, Panico Salvatore, Sacerdote Carlotta, Ardissino Diego, Asselta Rosanna, Matullo Giuseppe

机构信息

Genomic Variation, Complex Diseases and Population Medicine Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Cancer Registry and Histopathology Unit, Azienda Ospedaliera "Civile-M.P. Arezzo", 97100 Ragusa, Italy.

出版信息

J Pers Med. 2024 Sep 26;14(10):1025. doi: 10.3390/jpm14101025.

Abstract

BACKGROUND/OBJECTIVES: The identification of coronary artery disease (CAD) high-risk individuals is a major clinical need for timely diagnosis and intervention. Many different polygenic scores (PGSs) for CAD risk are available today to estimate the genetic risk. It is necessary to carefully choose the score to use, in particular for studies on populations, which are not adequately represented in the large datasets of European biobanks, such as the Italian one. This work aimed to analyze which PGS had the best performance within the Italian population.

METHODS

We used two Italian independent cohorts: the EPICOR case-control study (576 individuals) and the Atherosclerosis, Thrombosis, and Vascular Biology (ATVB) Italian study (3359 individuals). We evaluated 266 PGS for cardiovascular disease risk from the PGS Catalog, selecting 51 for CAD.

RESULTS

Distributions between patients and controls were significantly different for 49 scores (-value < 0.01). Only five PGS have been trained and tested for the European population specifically. PGS003727 demonstrated to be the most accurate when evaluated independently (EPICOR AUC = 0.68; ATVB AUC = 0.80). Taking into account the conventional CAD risk factors further enhanced the performance of the model, particularly in the ATVB study (-value = 0.0003).

CONCLUSIONS

European CAD PGS could have different risk estimates in peculiar populations, such as the Italian one, as well as in various geographical macro areas. Therefore, further evaluation is recommended for clinical applicability.

摘要

背景/目的:识别冠状动脉疾病(CAD)高危个体是及时诊断和干预的一项主要临床需求。如今有许多不同的用于评估CAD风险的多基因评分(PGS)来估计遗传风险。有必要谨慎选择要使用的评分,特别是对于那些在欧洲生物样本库的大型数据集中未得到充分体现的人群(如意大人群)所开展的研究。这项工作旨在分析哪种PGS在意大利人群中表现最佳。

方法

我们使用了两个意大利独立队列:EPICOR病例对照研究(576人)和意大利动脉粥样硬化、血栓形成与血管生物学(ATVB)研究(3359人)。我们从PGS目录中评估了266个心血管疾病风险的PGS,筛选出51个用于CAD的评分。

结果

49个评分在患者和对照之间的分布存在显著差异(P值<0.01)。只有5个PGS专门针对欧洲人群进行了训练和测试。PGS003727在独立评估时表现最为准确(EPICOR研究中AUC = 0.68;ATVB研究中AUC = 0.80)。考虑传统CAD危险因素进一步提高了模型的性能,特别是在ATVB研究中(P值 = 0.0003)。

结论

欧洲CAD的PGS在特殊人群(如意大人群)以及不同地理大区可能有不同的风险估计。因此,建议进一步评估其临床适用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8588/11508882/fce257bcabd3/jpm-14-01025-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验